Prime Medicine Logo

Prime Medicine

🇺🇸
PRME
US74168J1016

Prime Medicine is a leading biotechnology company focused on precise gene editing. Utilizing its innovative Prime Editing technology, it is developing transformative therapies to address a wide spectrum of genetic diseases. The company aims to fundamentally correct genomic defects, revolutionizing medicine.

Next Quarterly Earnings

Friday, October 30, 2026
CW 44
Pre-Market
In 64 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 2, 2026

Stock Price

Frequently asked questions

When will Prime Medicine report its next quarterly earnings?

Prime Medicine is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Prime Medicine last report quarterly earnings?

Prime Medicine last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.24 USD.

How does Prime Medicine stock react to earnings?

Across its last 3 earnings reports, Prime Medicine stock moved by ±10.5% on average the following day. The largest reaction was +13.6% on 10/31/2025; 1 of 3 reactions were positive.

How often has Prime Medicine beaten expectations?

Prime Medicine has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the Prime Medicine earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.24
Actual:
Q2 2026
Beat
Estimate:-$0.26
Actual:-$0.24
Difference:+$0.02
Q1 2026
Missed
Estimate:-$0.25
Actual:-$0.28
Difference:-$0.03
Price reaction (1 day):-8.7 %
Price reaction (7 days):-8.2 %
Q4 2025
Beat
Estimate:-$0.27
Actual:-$0.22
Difference:+$0.05
Price reaction (1 day):-9.2 %
Price reaction (7 days):-13.1 %
Q3 2025
Missed
Estimate:-$0.25
Actual:-$0.32
Difference:-$0.07
Price reaction (1 day):+13.6 %
Price reaction (7 days):-12.4 %
Q1 2025
Missed
Estimate:-$0.34
Actual:-$0.41
Difference:-$0.07

Earnings statistics

Stock reaction to earnings

±10.5%
Avg. next-day move
+13.6%
Largest move (10/31/2025)
33.3%
Share of positive reactions
±11.2%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
+2.4%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Prime Medicine
Ticker Symbol
PRME
ISIN
US74168J1016
Country
🇺🇸
USA
Sector
More Financial Information